WX

Corgi All World 2x Daily ETF

Leveraged / InverseBATSCorgi ETF
$25.56
$-0.01 (-0.02%)
Real-time · Aug 14, 2026 1:33 PM ET

Key Statistics

Net Assets (AUM)
$1.81B
Expense Ratio
See prospectus
Previous Close
$25.57
Day Range
$25.56 – $25.56
52-Week Range
$20.48 – $25.57
Volume
18
Avg Vol (50D)
-
Beta
2.15

Historical Performance

1M
+6.18%
3M
6M
YTD
1Y
+2.05%
3Y
5Y

Total return including reinvested distributions, from adjusted closing prices.

Price History

Price history is being compiled for this fund.

Top Holdings

Detailed holdings are compiled from each fund’s latest SEC N-PORT portfolio filing.

About WX

DELISTED - WuXi PharmaTech (Cayman) Inc. (WuXi) is a pharmaceutical, biotechnology and medical device research and development (R&D) outsourcing company, with operations in People's Republic of China and the United States. The Company provides a portfolio of laboratory and manufacturing services throughout the R&D process to its customers, which include the world's pharmaceutical, biotechnology and medical device companies. Its services are designed to assist its global customers in shortening the time and lowering the cost of pharmaceutical and medical device R&D by providing outsourcing solutions. WuXi's business has been to provide discovery chemistry services to synthesize small molecules at the beginning of the drug discovery process. The Company has two segments: Laboratory services and Manufacturing services segment.

WX News

  • No recent news found for WX.

Data for WX is aggregated from third-party providers (Tiingo, Nasdaq, Finnhub) and SEC filings, may be delayed at least 20 minutes, and may be incomplete or contain errors. Nothing here is investment advice. Verify with the official prospectus before investing.